← Eichor
Study identifier: NCT07126821 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data

Condition: Brain (Nervous System) Cancers · Brain Arterial Disease · Neuro-Degenerative Disease  ·  Sponsor: Xiangya Hospital of Central South University

PhaseN/A
Planned participants100000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The goal of this observational study is to develop an innovative, comprehensive, and explainable AI vision-language foundation model (VLM) to advance the diagnosis and interpretation of brain diseases using multi-modal data. We will include patient demographics, medical imaging data (such as MRI, CT, and PET scans), histopathological data, genomic data when available, and other necessary laboratory examinations and tests to establish a screening and diagnostic model for brain diseases.

This description comes directly from the study's public registry record.

Talk to the study team

Xuan Gong, PhD.  ·  0086-731-8975-3037  ·  gong.xuan@csu.edu.cn

Zhou Chen, PhD.  ·  0086-13687397913  ·  czad0412@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xiangya Hospital of Central South UniversityChangsha, Hunan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07126821